| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594381 | American Heart Journal | 2017 | 23 Pages |
Abstract
The REVEAL trial will provide a robust evaluation of the clinical efficacy and safety of adding anacetrapib to an effective statin regimen. Results are anticipated in 2017.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
M.J. Landray, REVEAL Collaborative Group REVEAL Collaborative Group, L. Bowman, F. Chen, E. Sammons, J.C. Hopewell, K. Wallendszus, W. Stevens, E. Valdes-Marquez, S. Wiviott, C.P. Cannon, E. Braunwald, R. Collins,